Listed

Intelligent Bio Solutions Inc.

INBSNasdaqCIK 1725430HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.1m, Q4 FY2026
Operating income−$4.0m, Q4 FY2026
Net income−$3.9m, Q4 FY2026
Intelligent Bio Solutions Inc., income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$k796Revenue, Q1 FY2024, three months to 2023-09-30$796.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure764Revenue, Q2 FY2024, three months to 2023-12-31$764.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure824Revenue, Q3 FY2024, three months to 2024-03-31$823.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure728Revenue, Q4 FY2024, three months to 2024-06-30$727.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure872Revenue, Q1 FY2025, three months to 2024-09-30$872.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure607Revenue, Q2 FY2025, three months to 2024-12-31$607.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure729Revenue, Q3 FY2025, three months to 2025-03-31$728.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure844Revenue, Q4 FY2025, three months to 2025-06-30$843.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure1,112Revenue, Q1 FY2026, three months to 2025-09-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure897Revenue, Q2 FY2026, three months to 2025-12-31$896.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure1,061Revenue, Q3 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure1,146Revenue, Q4 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Cost of revenue$k564Cost of revenue, Q1 FY2024, three months to 2023-09-30$563.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure565Cost of revenue, Q2 FY2024, three months to 2023-12-31$564.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure645Cost of revenue, Q3 FY2024, three months to 2024-03-31$645.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure(87.7)Cost of revenue, Q4 FY2024, three months to 2024-06-30−$87.7k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure525Cost of revenue, Q1 FY2025, three months to 2024-09-30$525.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure384Cost of revenue, Q2 FY2025, three months to 2024-12-31$384.4k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure387Cost of revenue, Q3 FY2025, three months to 2025-03-31$387.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure508Cost of revenue, Q4 FY2025, three months to 2025-06-30$508.3k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure594Cost of revenue, Q1 FY2026, three months to 2025-09-30$593.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure437Cost of revenue, Q2 FY2026, three months to 2025-12-31$437.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure525Cost of revenue, Q3 FY2026, three months to 2026-03-31$525.4k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure609Cost of revenue, Q4 FY2026, three months to 2026-06-30$609.2k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Gross profit$k232Gross profit, Q1 FY2024, three months to 2023-09-30$232.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure199Gross profit, Q2 FY2024, three months to 2023-12-31$199.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure178Gross profit, Q3 FY2024, three months to 2024-03-31$178.5k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure816Gross profit, Q4 FY2024, three months to 2024-06-30$815.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure347Gross profit, Q1 FY2025, three months to 2024-09-30$346.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure223Gross profit, Q2 FY2025, three months to 2024-12-31$223.1k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure341Gross profit, Q3 FY2025, three months to 2025-03-31$341.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure336Gross profit, Q4 FY2025, three months to 2025-06-30$335.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure518Gross profit, Q1 FY2026, three months to 2025-09-30$518.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure460Gross profit, Q2 FY2026, three months to 2025-12-31$459.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure535Gross profit, Q3 FY2026, three months to 2026-03-31$535.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure537Gross profit, Q4 FY2026, three months to 2026-06-30$536.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Research and development$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$knot reported1,705Selling, general and administrative, Q2 FY2024, three months to 2023-12-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figurenot reportednot reportednot reported1,809Selling, general and administrative, Q2 FY2025, three months to 2024-12-31$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure2,415Selling, general and administrative, Q3 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure2,723Selling, general and administrative, Q4 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2,337Selling, general and administrative, Q2 FY2026, three months to 2025-12-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure2,459Selling, general and administrative, Q3 FY2026, three months to 2026-03-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure2,990Selling, general and administrative, Q4 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$k(2,526)Operating income, Q1 FY2024, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure(1,991)Operating income, Q2 FY2024, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure(2,954)Operating income, Q3 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure(2,812)Operating income, Q4 FY2024, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure(2,725)Operating income, Q1 FY2025, three months to 2024-09-30−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2,264)Operating income, Q2 FY2025, three months to 2024-12-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(2,560)Operating income, Q3 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(3,106)Operating income, Q4 FY2025, three months to 2025-06-30−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure(3,000)Operating income, Q1 FY2026, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2,636)Operating income, Q2 FY2026, three months to 2025-12-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(2,947)Operating income, Q3 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(3,969)Operating income, Q4 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$k37.4Interest expense, Q1 FY2024, three months to 2023-09-30$37.4k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure32.5Interest expense, Q2 FY2024, three months to 2023-12-31$32.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure42.7Interest expense, Q3 FY2024, three months to 2024-03-31$42.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure54.6Interest expense, Q4 FY2024, three months to 2024-06-30$54.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure22.3Interest expense, Q1 FY2025, three months to 2024-09-30$22.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure13.5Interest expense, Q2 FY2025, three months to 2024-12-31$13.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure7.9Interest expense, Q3 FY2025, three months to 2025-03-31$7.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure5.3Interest expense, Q4 FY2025, three months to 2025-06-30$5.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure3.9Interest expense, Q1 FY2026, three months to 2025-09-30$3.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure56.2Interest expense, Q2 FY2026, three months to 2025-12-31$56.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure4.2Interest expense, Q3 FY2026, three months to 2026-03-31$4.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure3.3Interest expense, Q4 FY2026, three months to 2026-06-30$3.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Net income$k(2,425)Net income, Q1 FY2024, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure(1,970)Net income, Q2 FY2024, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure(2,978)Net income, Q3 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure(2,784)Net income, Q4 FY2024, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure(2,686)Net income, Q1 FY2025, three months to 2024-09-30−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2,249)Net income, Q2 FY2025, three months to 2024-12-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(2,544)Net income, Q3 FY2025, three months to 2025-03-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(3,090)Net income, Q4 FY2025, three months to 2025-06-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure(2,983)Net income, Q1 FY2026, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2,678)Net income, Q2 FY2026, three months to 2025-12-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(2,863)Net income, Q3 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(3,908)Net income, Q4 FY2026, three months to 2026-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(12.48)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$12.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure(2.07)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$2.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure(1.43)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$1.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figurenot reported(0.70)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(4.96)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$4.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(4.41)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$4.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2.82)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$2.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(1.80)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$1.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported
Basic EPS$ per share(12.48)Basic EPS, Q1 FY2024, three months to 2023-09-30−$12.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure(2.07)Basic EPS, Q2 FY2024, three months to 2023-12-31−$2.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure(1.43)Basic EPS, Q3 FY2024, three months to 2024-03-31−$1.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figurenot reported(0.70)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(4.96)Basic EPS, Q2 FY2025, three months to 2024-12-31−$4.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(4.41)Basic EPS, Q3 FY2025, three months to 2025-03-31−$4.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported(0.35)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2.82)Basic EPS, Q2 FY2026, three months to 2025-12-31−$2.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(1.80)Basic EPS, Q3 FY2026, three months to 2026-03-31−$1.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported

Balance sheet

Cash and equivalents$4.0m, FY2026
Long-term debt$1.6m, period not labelled
Shareholders' equity$5.5m, FY2026
Intelligent Bio Solutions Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-12-31Q3 FY20242024-03-31period not labelled2024-04-16FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m1.1Cash and equivalents, Q2 FY2024, at 2023-12-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure9.4Cash and equivalents, Q3 FY2024, at 2024-03-31$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported6.3Cash and equivalents, FY2024, at 2024-06-30$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure4.0Cash and equivalents, Q1 FY2025, at 2024-09-30$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure2.2Cash and equivalents, Q2 FY2025, at 2024-12-31$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure2.8Cash and equivalents, Q3 FY2025, at 2025-03-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure1.0Cash and equivalents, FY2025, at 2025-06-30$1.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure1.7Cash and equivalents, Q1 FY2026, at 2025-09-30$1.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure0.7Cash and equivalents, Q2 FY2026, at 2025-12-31$740.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure6.9Cash and equivalents, Q3 FY2026, at 2026-03-31$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure4.0Cash and equivalents, FY2026, at 2026-06-30$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Current assets$m2.9Current assets, Q2 FY2024, at 2023-12-31$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure11.5Current assets, Q3 FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported8.5Current assets, FY2024, at 2024-06-30$8.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure6.5Current assets, Q1 FY2025, at 2024-09-30$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure4.1Current assets, Q2 FY2025, at 2024-12-31$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure5.1Current assets, Q3 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure4.1Current assets, FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure4.5Current assets, Q1 FY2026, at 2025-09-30$4.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure12.2Current assets, Q2 FY2026, at 2025-12-31$12.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure9.7Current assets, Q3 FY2026, at 2026-03-31$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure7.1Current assets, FY2026, at 2026-06-30$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Total assets$m8.8Total assets, Q2 FY2024, at 2023-12-31$8.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure17.0Total assets, Q3 FY2024, at 2024-03-31$17.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported13.8Total assets, FY2024, at 2024-06-30$13.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure11.7Total assets, Q1 FY2025, at 2024-09-30$11.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure8.7Total assets, Q2 FY2025, at 2024-12-31$8.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure9.6Total assets, Q3 FY2025, at 2025-03-31$9.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure8.2Total assets, FY2025, at 2025-06-30$8.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure10.0Total assets, Q1 FY2026, at 2025-09-30$10.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure17.7Total assets, Q2 FY2026, at 2025-12-31$17.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure14.9Total assets, Q3 FY2026, at 2026-03-31$14.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure11.9Total assets, FY2026, at 2026-06-30$11.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Current liabilities$m5.2Current liabilities, Q2 FY2024, at 2023-12-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure5.7Current liabilities, Q3 FY2024, at 2024-03-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported5.5Current liabilities, FY2024, at 2024-06-30$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure5.7Current liabilities, Q1 FY2025, at 2024-09-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure4.4Current liabilities, Q2 FY2025, at 2024-12-31$4.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure4.6Current liabilities, Q3 FY2025, at 2025-03-31$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure5.4Current liabilities, FY2025, at 2025-06-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure5.1Current liabilities, Q1 FY2026, at 2025-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure5.1Current liabilities, Q2 FY2026, at 2025-12-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure4.6Current liabilities, Q3 FY2026, at 2026-03-31$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure4.9Current liabilities, FY2026, at 2026-06-30$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Total liabilities$m5.7Total liabilities, Q2 FY2024, at 2023-12-31$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure6.0Total liabilities, Q3 FY2024, at 2024-03-31$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported5.6Total liabilities, FY2024, at 2024-06-30$5.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure5.8Total liabilities, Q1 FY2025, at 2024-09-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure4.5Total liabilities, Q2 FY2025, at 2024-12-31$4.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure4.6Total liabilities, Q3 FY2025, at 2025-03-31$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure5.4Total liabilities, FY2025, at 2025-06-30$5.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure6.6Total liabilities, Q1 FY2026, at 2025-09-30$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure6.8Total liabilities, Q2 FY2026, at 2025-12-31$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure6.1Total liabilities, Q3 FY2026, at 2026-03-31$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure6.7Total liabilities, FY2026, at 2026-06-30$6.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Long-term debt$mnot reportednot reported1.7Long-term debt, period not labelled, at 2024-04-16$1.6m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m3.3Shareholders' equity, Q2 FY2024, at 2023-12-31$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure11.1Shareholders' equity, Q3 FY2024, at 2024-03-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figurenot reported8.3Shareholders' equity, FY2024, at 2024-06-30$8.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure6.1Shareholders' equity, Q1 FY2025, at 2024-09-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure4.4Shareholders' equity, Q2 FY2025, at 2024-12-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure5.1Shareholders' equity, Q3 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure3.0Shareholders' equity, FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure3.6Shareholders' equity, Q1 FY2026, at 2025-09-30$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure11.1Shareholders' equity, Q2 FY2026, at 2025-12-31$11.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure9.0Shareholders' equity, Q3 FY2026, at 2026-03-31$9.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure5.5Shareholders' equity, FY2026, at 2026-06-30$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure

Cash flow

Operating cash flow−$3.2m, Q4 FY2026
Capital expenditure$0, Q4 FY2026
Intelligent Bio Solutions Inc., cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(1,312)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure(2,869)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-13, accession 0001493152-25-006262. Derived: 6-month figure less the 3-month figure.Report this figure(2,447)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001641172-25-009846. Derived: 9-month figure less the 6-month figure.Report this figure(2,944)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-15, accession 0001641172-25-024279. Derived: 12-month figure less the 9-month figure.Report this figure(2,387)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2,325)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001493152-26-006311. Derived: 6-month figure less the 3-month figure.Report this figure(2,755)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022617. Derived: 9-month figure less the 6-month figure.Report this figure(2,210)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure(2,847)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(1,568)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001493152-26-006311. Derived: 6-month figure less the 3-month figure.Report this figure(4,331)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022617. Derived: 9-month figure less the 6-month figure.Report this figure(3,182)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported70.4Capital expenditure, Q1 FY2026, three months to 2025-09-30$70.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure68.2Capital expenditure, Q2 FY2026, three months to 2025-12-31$68.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-12, accession 0001493152-26-006311. Derived: 6-month figure less the 3-month figure.Report this figure(12.9)Capital expenditure, Q3 FY2026, three months to 2026-03-31−$12.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022617. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)1.59m, Q3 FY2026
Intelligent Bio Solutions Inc., shares, quarterly
Line itemUnitQ1 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)k shares744Diluted shares (weighted), Q1 FY2023, three months to 2022-09-30744,495 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001493152-23-039898.Report this figure75.7Diluted shares (weighted), Q2 FY2023, three months to 2022-12-3175,690 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-09, accession 0001493152-24-005569.Report this figure92.4Diluted shares (weighted), Q3 FY2023, three months to 2023-03-3192,389 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001493152-24-018167.Report this figure194Diluted shares (weighted), Q1 FY2024, three months to 2023-09-30194,200 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001493152-24-043927.Report this figure950Diluted shares (weighted), Q2 FY2024, three months to 2023-12-31949,660 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-13, accession 0001493152-25-006262.Report this figure2,080Diluted shares (weighted), Q3 FY2024, three months to 2024-03-312,079,864 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001641172-25-009846.Report this figure3,811Diluted shares (weighted), Q1 FY2025, three months to 2024-09-303,811,090 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure454Diluted shares (weighted), Q2 FY2025, three months to 2024-12-31453,582 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure577Diluted shares (weighted), Q3 FY2025, three months to 2025-03-31577,191 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure8,547Diluted shares (weighted), Q1 FY2026, three months to 2025-09-308,546,934 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure951Diluted shares (weighted), Q2 FY2026, three months to 2025-12-31950,829 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure1,594Diluted shares (weighted), Q3 FY2026, three months to 2026-03-311,594,496 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure

Shares outstanding: 3.03mShares outstanding, period not labelled, at 2026-08-183,027,470 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K/A filed 2026-10-21, accession 0001493152-26-047925.Report this figure at Aug 18, 2026, from the cover of the 10-K/A filed Oct 21, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.